SCHEMBL25040839

SCHEMBL25040839

CC(=O)C1=C(C)CN(SI)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25038288 0.66 KDM4E (0.33) —
SCHEMBL25040854 0.60 HSP90AA1 (0.33) —
SCHEMBL25040594 0.59 MMP2 (0.55) —
SCHEMBL12676700 0.57 ALDH1A1 (0.36) —
SCHEMBL13306010 0.56 SMN1; SMN2 (0.33) —
SCHEMBL16346219 0.54 HSP90AA1 (0.32) —
SCHEMBL14514830 0.53 SMN1; SMN2 (0.32) —
SCHEMBL25040165 0.53 KDM4E (0.30) —
SCHEMBL10143995 0.51 NOTUM (0.52) —
SCHEMBL1917003 0.48 HSP90AA1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018215-A1 METHOD FOR SYNTHESIZING BILIRUBIN 주식회사 빌릭스 2023-02-16 — — WO disclosed
Send feedback